Zosano Pharma Corporation ZSAN
$ 0.56
7.23%
Quarterly report 2022-Q1
added 12-23-2023
Country |
USA |
IPO year |
2015 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Steven Lo |
Employees in the company |
56 |
Shares |
112 M |
Market Cap[1] |
$ 2.72 M |
EBITDA (LTM) |
$ -56.4 M |
P/E (LTM) |
-0.05 |
P/S (LTM) |
3.28 |
EPS (LTM) |
-10.72 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.